![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 207/14 | |
A61K 31/402 | |||
A61P 5/20 | |||
A61P 43/00 |
(11) | Number of the document | 3042893 |
(13) | Kind of document | T |
(96) | European patent application number | 14842038.3 |
Date of filing the European patent application | 2014-09-05 | |
(97) | Date of publication of the European application | 2016-07-13 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2014/073426 |
Date | 2014-09-05 |
(87) | Number | WO 2015/034031 |
Date | 2015-03-12 |
(30) | Number | Date | Country code |
PCT/JP2013/0739 | 2013-09-05 | WO |
(72) |
MIYAZAKI, Hiroshi, JP
KOMASAKA, Takao, JP
TSURUMOTO, Joji, JP
UEMURA, Takeshi, JP
MORITA, Yuuji, JP
|
(73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka 541-8505,
JP
|
(54) | NOVEL CRYSTALLINE ARYLALKYLAMINE COMPOUND AND METHOD FOR PRODUCING SAME |
NOVEL CRYSTALLINE ARYLALKYLAMINE COMPOUND AND METHOD FOR PRODUCING SAME |